This discrepancy suggests that pathophysiological redox changes in the serum apoE-Cys-thiol by or for the development of atherosclerosis accompanied by dyslipidemia would be quite different from those by or for the development of dyslipidemia without atherosclerosis. The gene discussed is APOE; the disease is metabolic syndrome.